Postnatal Magnesium Trend in less than 34 week Preterms who received Antenatal Neuroprotective Doses of Magnesium Sulphate

Abstract

Antenatal magnesium sulphate is one of the neuro protective strategies used for preterm deliveries. One of the concerns with this is whether it leads to hypermagnesemia in newborns. Postnatal magnesium levels were studied in 70 preterms whose mothers received magnesium sulphate. No baby had hypermagnesemia. The mean cord blood magnesium level was 2.76 mg/dl which came down to 2.37 mg/dl by 24 hours of life. Babies who needed labour room resuscitation had slightly elevated cord blood magnesium.